| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |